Drug Type Degradable Molecular Glue |
Synonyms BAY 2666605, BAY2666605, SLFN12 CI |
Target |
Action inhibitors |
Mechanism PDE3A inhibitors(phosphodiesterase 3A inhibitors), SLFN12 inhibitors(schlafen family member 12 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Molecular FormulaC17H12F4N2O2 |
InChIKeyJNTJTCXFIXNXDV-VIFPVBQESA-N |
CAS Registry2275774-60-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced cancer | Phase 1 | United States | 15 Apr 2021 | |
Advanced Malignant Solid Neoplasm | Phase 1 | United States | 15 Apr 2021 | |
Metastatic melanoma | Phase 1 | United States | 15 Apr 2021 | |
Ovarian Cancer | Phase 1 | United States | 15 Apr 2021 | |
Sarcoma | Phase 1 | United States | 15 Apr 2021 |